Risk of Paradoxical Eczema in Patients Receiving Biologics for Psoriasis
2023 · JAMA Dermatology · 54 citations
https://doi.org/10.1001/jamadermatol.2023.4846
A
Ali Al‐Janabi
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
27
Papers
429
Citations
13
h-index
14
i10-index
Ali Al‐Janabi is an academic researcher from Manchester Academic Health Science Centre. The author has contributed to research in topics: Psoriasis: Treatment and Pathogenesis & Dermatology and Skin Diseases & Asthma and respiratory diseases. The author has an h-index of 13, co-authored 23 publications.
ORCID: 0000-0002-2094-0556Papers by this author
worksAtopic Polygenic Risk Score Is Associated with Paradoxical Eczema Developing in Patients with Psoriasis Treated with Biologics
2023 · Journal of Investigative Dermatology · 22 citations
https://doi.org/10.1016/j.jid.2023.01.021
Integrated proteomics and genomics analysis of paradoxical eczema in psoriasis patients treated with biologics
2023 · Journal of Allergy and Clinical Immunology · 17 citations
https://doi.org/10.1016/j.jaci.2023.07.011
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat